Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Harry Cheuk Hay Lau, Joseph Jao-Yiu Sung & Jun Yu. (2021) Gut microbiota: impacts on gastrointestinal cancer immunotherapy. Gut Microbes 13:1.
Read now
Read now
Nourhan Hossam, Marwa Matboli, Hanan H. Shehata, Marwa M. Aboelhussein, Mohamed Kamel Hassan & Sanaa Eissa. (2020) Toll-like receptor immune modulatory role in personalized management of colorectal cancer, review of literature. Expert Review of Precision Medicine and Drug Development 5:6, pages 455-468.
Read now
Read now
Fernando Aranda, Erika Vacchelli, Florine Obrist, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Isabelle Cremer, Jan Henrik ter Meulen, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:6.
Read now
Read now
Fernando Aranda, Erika Vacchelli, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial Watch. OncoImmunology 2:12.
Read now
Read now
Erika Vacchelli, Alexander Eggermont, Catherine Sautès-Fridman, Jerome Galon, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial Watch. OncoImmunology 2:8.
Read now
Read now
Cesar A Perez, Edgardo S Santos & Luis E Raez. (2011) Active immunotherapy for non-small-cell lung cancer: moving toward a reality. Expert Review of Anticancer Therapy 11:10, pages 1599-1605.
Read now
Read now
Angela M Bodles-Brakhop & Ruxandra Draghia-Akli. (2008) DNA vaccination and gene therapy: optimization and delivery for cancer therapy. Expert Review of Vaccines 7:7, pages 1085-1101.
Read now
Read now
Articles from other publishers (36)
Enrica Marmonti, Jacqueline Oliva-Ramirez & Cara Haymaker. (2022) Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer. Cells 11:19, pages 3028.
Crossref
Crossref
Dipyaman GangulyDipyaman Ganguly. 2022. Plasmacytoid Dendritic Cells. Plasmacytoid Dendritic Cells
147
160
.
Hua Wang, Alexander J. Najibi, Miguel C. Sobral, Bo Ri Seo, Jun Yong Lee, David Wu, Aileen Weiwei Li, Catia S. Verbeke & David J. Mooney. (2020) Biomaterial-based scaffold for in situ chemo-immunotherapy to treat poorly immunogenic tumors. Nature Communications 11:1.
Crossref
Crossref
Noemi Eiro, Luis Gonzalez, María Fraile, Sandra Cid, Jose Schneider & Francisco Vizoso. (2019) Breast Cancer Tumor Stroma: Cellular Components, Phenotypic Heterogeneity, Intercellular Communication, Prognostic Implications and Therapeutic Opportunities. Cancers 11:5, pages 664.
Crossref
Crossref
Noemi Eiro, Sandra Cid, María Fraile & Francisco J. Vizoso. (2019) Importancia de la investigación sobre el estroma tumoral en el cáncer de mama. Revista de Senología y Patología Mamaria 32:1, pages 17-25.
Crossref
Crossref
Reyhaneh Moradi‐Marjaneh, Seyed Mahdi Hassanian, Hamid Fiuji, Saman Soleimanpour, Gordon A. Ferns, Amir Avan & Majid Khazaei. (2018) Toll like receptor signaling pathway as a potential therapeutic target in colorectal cancer. Journal of Cellular Physiology 233:8, pages 5613-5622.
Crossref
Crossref
Kosuke Tanegashima, Rena Takahashi, Hideko Nuriya, Rina Iwase, Naoto Naruse, Kohei Tsuji, Akira Shigenaga, Akira Otaka & Takahiko Hara. (2017) CXCL14 Acts as a Specific Carrier of CpG DNA into Dendritic Cells and Activates Toll-like Receptor 9-mediated Adaptive Immunity. EBioMedicine 24, pages 247-256.
Crossref
Crossref
Wei He, Pei Liang, Guangxing Guo, Zhen Huang, Yiming Niu, Lei Dong, Chunming Wang & Junfeng Zhang. (2016) Re-polarizing Myeloid-derived Suppressor Cells (MDSCs) with Cationic Polymers for Cancer Immunotherapy. Scientific Reports 6:1.
Crossref
Crossref
Barbara Behm, Pietro Di Fazio, Patrick Michl, Daniel Neureiter, Ralf Kemmerling, Eckhart Georg Hahn, Deike Strobel, Thomas Gress, Detlef Schuppan & Thaddaeus Till Wissniowski. (2016) Additive antitumour response to the rabbit VX2 hepatoma by combined radio frequency ablation and toll like receptor 9 stimulation. Gut 65:1, pages 134-143.
Crossref
Crossref
Masahiro Katsuda & Hiroki Yamaue. 2016. Immunotherapy of Cancer. Immunotherapy of Cancer
223
233
.
NIRIANNE MARIE Q. PALACPAC, TAKAHIRO TOUGAN & TOSHIHIRO HORII. (2015) Preclinical Studies on a New Vaccine Formulation of BK-SE36, a Malaria Vaccine Candidate. Juntendo Medical Journal 61:4, pages 360-369.
Crossref
Crossref
Lorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, Aitziber Buqué, Laura Senovilla, Elisa Elena Baracco, Norma Bloy, Francesca Castoldi, Jean-Pierre Abastado, Patrizia Agostinis, Ron N. Apte, Fernando Aranda, Maha Ayyoub, Philipp Beckhove, Jean-Yves Blay, Laura Bracci, Anne Caignard, Chiara Castelli, Federica Cavallo, Estaban Celis, Vincenzo Cerundolo, Aled Clayton, Mario P. Colombo, Lisa Coussens, Madhav V. Dhodapkar, Alexander M. Eggermont, Douglas T. Fearon, Wolf H. Fridman, Jitka Fučíková, Dmitry I. Gabrilovich, Jérôme Galon, Abhishek Garg, François Ghiringhelli, Giuseppe Giaccone, Eli Gilboa, Sacha Gnjatic, Axel Hoos, Anne Hosmalin, Dirk Jäger, Pawel Kalinski, Klas Kärre, Oliver Kepp, Rolf Kiessling, John M. Kirkwood, Eva Klein, Alexander Knuth, Claire E. Lewis, Roland Liblau, Michael T. Lotze, Enrico Lugli, Jean-Pierre Mach, Fabrizio Mattei, Domenico Mavilio, Ignacio Melero, Cornelis J. Melief, Elizabeth A. Mittendorf, Lorenzo Moretta, Adekunke Odunsi, Hideho Okada, Anna Karolina Palucka, Marcus E. Peter, Kenneth J. Pienta, Angel Porgador, George C. Prendergast, Gabriel A. Rabinovich, Nicholas P. Restifo, Naiyer Rizvi, Catherine Sautès-Fridman, Hans Schreiber, Barbara Seliger, Hiroshi Shiku, Bruno Silva-Santos, Mark J. Smyth, Daniel E. Speiser, Radek Spisek, Pramod K. Srivastava, James E. Talmadge, Eric Tartour, Sjoerd H. Van Der Burg, Benoît J. Van Den Eynde, Richard Vile, Hermann Wagner, Jeffrey S. Weber, Theresa L. Whiteside, Jedd D. Wolchok, Laurence Zitvogel, Weiping Zou & Guido Kroemer. (2014) Classification of current anticancer immunotherapies. Oncotarget 5:24, pages 12472-12508.
Crossref
Crossref
Guo-Xing Wan, Yu-Wen Cao, Wen-Qin Li, Yu-Cong Li, Wen-Jie Zhang & Feng Li. (2014) Associations Between TLR9 Polymorphisms and Cancer Risk: Evidence from an Updated Meta-analysis of 25,685 Subjects. Asian Pacific Journal of Cancer Prevention 15:19, pages 8279-8285.
Crossref
Crossref
Juan Fu, Ian-James Malm, Deepak K. Kadayakkara, Hy Levitsky, Drew Pardoll & Young J. Kim. (2014) Preclinical Evidence That PD1 Blockade Cooperates with Cancer Vaccine TEGVAX to Elicit Regression of Established Tumors. Cancer Research 74:15, pages 4042-4052.
Crossref
Crossref
Vivek K. Sharma, Raman K. Sharma & Sunil K. Singh. (2014) Antisense oligonucleotides: modifications and clinical trials. Med. Chem. Commun. 5:10, pages 1454-1471.
Crossref
Crossref
Paweł Bodera, Wanda Stankiewicz & Janusz Kocik. (2012) Synthetic immunostimulatory oligonucleotides in experimental and clinical practice. Pharmacological Reports 64:5, pages 1003-1010.
Crossref
Crossref
Xiaojun ChenSumin WangLi LiuZengyan ChenFulin QiangYanjing KanYan ShenJiangping WuHongbing ShenZhibin Hu. (2012) A Genetic Variant in the Promoter Region of Toll-Like Receptor 9 and Cervical Cancer Susceptibility. DNA and Cell Biology 31:5, pages 766-771.
Crossref
Crossref
Yuko Shirota, Hidekazu Shirota & Dennis M. Klinman. (2012) Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells. The Journal of Immunology 188:4, pages 1592-1599.
Crossref
Crossref
Michele Sommariva, Loris De Cecco, Michelandrea De Cesare, Lucia Sfondrini, Sylvie Ménard, Cecilia Melani, Domenico Delia, Nadia Zaffaroni, Graziella Pratesi, Valentina Uva, Elda Tagliabue & Andrea Balsari. (2011) TLR9 Agonists Oppositely Modulate DNA Repair Genes in Tumor versus Immune Cells and Enhance Chemotherapy Effects. Cancer Research 71:20, pages 6382-6390.
Crossref
Crossref
Bethany L. Mundy-Bosse, Gregory B. Lesinski, Alena C. Jaime-Ramirez, Kristen Benninger, Mahmood Khan, Periannan Kuppusamy, Kristan Guenterberg, Sri Vidya Kondadasula, Abhik Ray Chaudhury, Krista M. La Perle, Melanie Kreiner, Gregory Young, Denis C. Guttridge & William E. CarsonIIIIII. (2011) Myeloid-Derived Suppressor Cell Inhibition of the IFN Response in Tumor-Bearing Mice. Cancer Research 71:15, pages 5101-5110.
Crossref
Crossref
Meghan B. Davis, David Vasquez-Dunddel, Juan Fu, Emilia Albesiano, Drew Pardoll & Young J. Kim. (2011) Intratumoral Administration of TLR4 Agonist Absorbed into a Cellular Vector Improves Antitumor Responses. Clinical Cancer Research 17:12, pages 3984-3992.
Crossref
Crossref
Gregory E Holt, Eckhard R Podack & Luis E Raez. (2011) Immunotherapy as a strategy for the treatment of non-small-cell lung cancer. Therapy 8:1, pages 43-54.
Crossref
Crossref
Denise Richardt-Pargmann, Miriam Wechsler, Arthur M. Krieg, Jörg Vollmer & Marion Jurk. (2011) Positive T cell co-stimulation by TLR7/8 ligands is dependent on the cellular environment. Immunobiology 216:1-2, pages 12-23.
Crossref
Crossref
Salomé González-Reyes, Laura Marín, Lucía González, Luis O González, José M del Casar, Maria L Lamelas, José M González-Quintana & Francisco J Vizoso. (2010) Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. BMC Cancer 10:1.
Crossref
Crossref
Zachary C. Hartman, Takuya Osada, Oliver Glass, Xiao Y. Yang, Gang-jun Lei, H. Kim Lyerly & Timothy M. Clay. (2010) Ligand-Independent Toll-like Receptor Signals Generated by Ectopic Overexpression of MyD88 Generate Local and Systemic Antitumor Immunity. Cancer Research 70:18, pages 7209-7220.
Crossref
Crossref
Andrés Hernando-InsúaJuan M. RodriguezFernanda ElíasJuan FlóRicardo LópezRaul FrancoNestor LagoJorge ZorzopulosAlejandro D. Montaner. (2010) A High Dose of IMT504, the PyNTTTTGT Prototype Immunostimulatory Oligonucleotide, Does Not Alter Embryonic Development in Rats. Oligonucleotides 20:1, pages 33-36.
Crossref
Crossref
Angelo Corti, Monica Giovannini, Carmen Belli & Eugenio Villa. (2010) Immunomodulatory Agents with Antivascular Activity in the Treatment of Non-Small Cell Lung Cancer: Focus on TLR9 Agonists, IMiDs and NGR-TNF. Journal of Oncology 2010, pages 1-8.
Crossref
Crossref
Thomas E. Ichim, Robert J. Harman, Wei-Ping Min, Boris Minev, Fabio Solano, Jorge Paz Rodriguez, Doru T. Alexandrescu, Rosalia De Necochea-Campion, Xiang Hu, Annette M. Marleau & Neil H. Riordan. (2010) Autologous stromal vascular fraction cells: A tool for facilitating tolerance in rheumatic disease. Cellular Immunology 264:1, pages 7-17.
Crossref
Crossref
Issaka Sagara, Ruth D. Ellis, Alassane Dicko, Mohamed B. Niambele, Beh Kamate, Ousmane Guindo, Mahamadou S. Sissoko, Michael P. Fay, Merepen A. Guindo, Ousmane Kante, Renion Saye, Kazutoyo Miura, Carole Long, Gregory E.D. Mullen, Mark Pierce, Laura B. Martin, Kelly Rausch, Amagana Dolo, Dapa A. Diallo, Louis H. Miller & Ogobara K. Doumbo. (2009) A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel®+CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults. Vaccine 27:52, pages 7292-7298.
Crossref
Crossref
Alain P. Vicari, Rachel Luu, Ningli Zhang, Shobhna Patel, Shawn R. Makinen, Douglas C. Hanson, Risini D. Weeratna & Arthur M. Krieg. (2008) Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse. Cancer Immunology, Immunotherapy 58:4, pages 615-628.
Crossref
Crossref
George J. Weiner. (2009) CpG oligodeoxynucleotide-based therapy of lymphoid malignancies. Advanced Drug Delivery Reviews 61:3, pages 263-267.
Crossref
Crossref
Daliah Shoshana Tamar Galinsky & Hovav Nechushtan. (2008) Mast cells and cancer—No longer just basic science. Critical Reviews in Oncology/Hematology 68:2, pages 115-130.
Crossref
Crossref
Stefan Nierkens, Martijn H. den Brok, Roger P.M. Sutmuller, Oliver M. Grauer, Erik Bennink, Mary E. Morgan, Carl G. Figdor, Theo J.M. Ruers & Gosse J. Adema. (2008)
In vivo
Colocalization of Antigen and CpG within Dendritic Cells Is Associated with the Efficacy of Cancer Immunotherapy
. Cancer Research 68:13, pages 5390-5396.
Crossref
Crossref
Niranjan B. Butchi, Susan Pourciau, Min Du, Tim W. Morgan & Karin E. Peterson. (2008) Analysis of the Neuroinflammatory Response to TLR7 Stimulation in the Brain: Comparison of Multiple TLR7 and/or TLR8 Agonists. The Journal of Immunology 180:11, pages 7604-7612.
Crossref
Crossref
Szilvia Benkő, Zoltán Magyarics, Attila Szabó & Éva Rajnavölgyi. (2008) Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors. bchm 389:5, pages 469-485.
Crossref
Crossref
Jorge Schettini & Pinku Mukherjee. (2008) Physiological Role of Plasmacytoid Dendritic Cells and Their Potential Use in Cancer Immunity. Clinical and Developmental Immunology 2008, pages 1-10.
Crossref
Crossref